Thomas E Long
CIK 1345700 · View on SEC EDGAR ↗
First SEC filing: Oct. 26, 2010 · Latest: Oct. 26, 2010
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2024 | ET | P | 20,000 | $15.68 | $313,600 | 4,308,859 Direct | +0.47% | Acquired | 36.7% (price as of 2026-08-19) |
| Feb. 27, 2024 | TCBIO | P | 2,000 | $58.78 | $117,560 | 7,542 Direct | +36.09% | Acquired | -65.0% (price as of 2026-08-19) |
| April 28, 2023 | TCBIO | P | 4,000 | $50.17 | $200,680 | 4,000 Direct | — | Acquired | -59.0% (price as of 2026-08-19) |
| Dec. 10, 2021 | ET | P | 80,546 | $7.45 | $600,068 | 1,634,868 Direct | +5.18% | Acquired | 187.7% (price as of 2026-08-19) |
| March 18, 2020 | ET | P | 9,000 | $4.14 | $37,260 | 819,498 Direct | +1.11% | Acquired | 417.6% (price as of 2026-08-19) |
| March 18, 2020 | ET | P | 9,000 | $4.36 | $39,240 | 810,498 Direct | +1.12% | Acquired | 391.5% (price as of 2026-08-19) |
| March 16, 2020 | ET | P | 9,000 | $5.62 | $50,580 | 801,498 Direct | +1.14% | Acquired | 281.3% (price as of 2026-08-19) |
| March 12, 2020 | ET | P | 6,000 | $5.91 | $35,460 | 792,498 Direct | +0.76% | Acquired | 262.6% (price as of 2026-08-19) |
| March 12, 2020 | ET | P | 3,000 | $5.90 | $17,700 | 786,498 Direct | +0.38% | Acquired | 263.2% (price as of 2026-08-19) |
| March 10, 2020 | ET | P | 17,700 | $7.00 | $123,900 | 783,498 Direct | +2.31% | Acquired | 206.1% (price as of 2026-08-19) |
| March 10, 2020 | ET | P | 300 | $7.00 | $2,100 | 765,798 Direct | +0.04% | Acquired | 206.1% (price as of 2026-08-19) |
| March 9, 2020 | ET | P | 18,000 | $7.40 | $133,200 | 765,498 Direct | +2.41% | Acquired | 189.6% (price as of 2026-08-19) |
| March 6, 2020 | ET | P | 9,000 | $10.64 | $95,760 | 747,498 Direct | +1.22% | Acquired | 101.4% (price as of 2026-08-19) |
| Feb. 27, 2020 | ET | P | 5,800 | $10.27 | $59,566 | 738,498 Direct | +0.79% | Acquired | 108.7% (price as of 2026-08-19) |
| Nov. 14, 2019 | ET | P | 18,000 | $11.15 | $200,700 | 517,698 Direct | +3.60% | Acquired | 92.2% (price as of 2026-08-19) |
| Dec. 24, 2018 | ET | P | 24,500 | $12.05 | $295,225 | 499,698 Direct | +5.16% | Acquired | 77.8% (price as of 2026-08-19) |
| Feb. 18, 2009 | MTRX | P | 2,000 | $7.33 | $14,660 | 45,501 Direct | +4.60% | Acquired | 56.6% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 28, 2026 | TCBIO | 2026 Restricted Stock Units | Common Stock (1,092) | $0.00 | — | 1,092 | Acquired |
| April 22, 2026 | TCBIO | 2025 Restricted Stock Units | Common Stock (1,670) | $0.00 | — | 1,670 | Disposed |
| Dec. 5, 2025 | ET | Cash Units | Common Units (234,812) | — | — | 234,812 | Acquired |
| April 23, 2025 | TCBIO | 2024 Restricted Stock Units | Common Stock (1,330) | $0.00 | — | 1,330 | Disposed |
| April 22, 2025 | TCBIO | 2025 Restricted Stock Units | Common Stock (1,670) | $0.00 | — | 1,670 | Acquired |
| Dec. 5, 2024 | ET | Cash Units | Common Units (213,000) | — | — | 213,000 | Acquired |
| April 23, 2024 | TCBIO | 2024 Restricted Stock Units | Common Stock (1,330) | $0.00 | — | 1,330 | Acquired |
| April 18, 2024 | TCBIO | Restricted Stock Units | Common Stock (1,631) | $0.00 | — | 1,631 | Disposed |
| Dec. 8, 2023 | ET | Cash Units | Common Units (260,712) | — | — | 260,712 | Acquired |
| May 16, 2023 | TCBIO | Restricted Stock Units | Common Stock (1,542) | $0.00 | — | 1,542 | Disposed |
| April 18, 2023 | TCBIO | Restricted Stock Units | Common Stock (1,631) | $0.00 | — | 1,631 | Acquired |
| Dec. 12, 2022 | ET | Cash Units | Common Units (319,650) | — | — | 319,650 | Acquired |
| Dec. 5, 2022 | ET | Phantom Units | Common Units (48,430) | $0.00 | Dec. 5, 2022 | 48,430 | Disposed |
| Dec. 16, 2021 | ET | Cash Units | Common Units (373,750) | — | — | 373,750 | Acquired |
| Dec. 30, 2020 | ET | Cash Units | Common Units (178,550) | — | — | 178,550 | Acquired |
| Dec. 4, 2020 | ET | Phantom Units | Common Units (72,644) | — | — | 72,644 | Disposed |
| Dec. 20, 2017 | ET | Phantom Units | Common Units [F1] (121,074) | — | — | 121,074 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 11, 2016 | SUN | Common Units | 14,125 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2011 | $150,433 | — | — | — | — | — | $714,612 | $865,045 |
| 2010 | $294,231 | — | — | — | — | — | $116,102 | $655,693 |
| 2008 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.